Blog: The Apothecary 

Pharmaceutical Sciences

Clinical Trial Underway To Test Plant-Based Gel’s Power To Boost Anti-Tumor Drugs

March 2, 2026

James Moon’s work has shown that a new plant-based fiber formulation may dramatically boost the tumor-fighting power of anti-cancer drugs. Now, he is collaborating with Michigan Medicine colleagues on a clinical trial to see if it can help patients fight kidney tumors.
A class of drugs called immune checkpoint blockers (ICBs) can spur the immune system […]

U-M Launches Institute for AI-Driven Therapeutics Discovery to Tackle Drug Development’s Toughest Problem

February 3, 2026

Bringing a new drug to patients is one of the most complex challenges in modern science. It can take 10 to 15 years and cost billions of dollars. On top of that, nearly 90% of drug candidates fail during clinical testing stages.
To confront this harsh reality, the University of Michigan has launched the Institute for […]

Helpful Hitchhikers: Exploiting the Brain’s Pathways to Develop and Deliver Treatments

November 20, 2025

Millions of people worldwide suffer from neurodegenerative diseases like Alzheimer’s, Parkinson’s and amyotrophic lateral sclerosis (ALS) that damage neurons in the brain. The need for therapies that can repair the damage—or prevent it—is enormous.
Treatments developed so far have had limited benefits, and one of the reasons is that it’s difficult to get a therapeutic dose […]

Combining a Passion for Mentorship and Science into a Standout Career

January 30, 2025

Maria Posada, Ph.D., considers herself lucky to be able to mix her passion for science and her love for coaching and mentorship into one career.

Reconsidering the Ancient Herb: A New Class Will Prepare Pharmacists for the Shifting Medical and Legal Cannabis Landscape

November 22, 2024

Gus Rosania, Professor of Pharmaceutical Sciences, has created a Medical Cannabis course to prepare the next generation of pharmacists to understand CBD and other cannabis-derived products.

James Moon, PhD: Advancing the Frontier of Immunoengineering

September 20, 2024

Early work shows promise for treating devastating diseases like cancer and food allergies and offers hope for millions, showing the potential of powerful discoveries still to come.

Focusing AI on the Root Causes to Find Better Cancer Drugs

September 11, 2024

Duxin Sun, PhD, has dedicated his career to developing anticancer drugs, cancer vaccines and nanomedicines for cancer therapy.

Engineering Enhanced Payloads for Cancer-Fighting Antibodies

August 8, 2024

Dr. Bordeau, who joined the College faculty in December 2023 from the University of Buffalo, is working to overcome the known issues of antibody delivery.

Developing a Drug to Stop a Silent Killer

January 23, 2024

Small, slow-growing aneurysms often cause no symptoms, but when they leak or rupture, they can be deadly.